Tandem Diabetes Care Inc (STU:TD5A)
€ 29.15 -1.65 (-5.36%) Market Cap: 1.92 Bil Enterprise Value: 1.92 Bil PE Ratio: 0 PB Ratio: 8.66 GF Score: 82/100

Tandem Diabetes Care Inc at Credit Suisse Healthcare Conference Transcript

Nov 08, 2022 / 09:25PM GMT
Release Date Price: €37.22 (+4.08%)
Unidentified Analyst

[Audio Gap] John Sheridan, President and CEO; and Leigh Vosseller, Executive Vice President and CFO. So the plan is I'm going to turn it over to you, John, and Leigh, who will walk us through the Tandem story, and then we'll have some time for Q&A at the end.

John?

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Okay. Thanks again. Well, good afternoon, everybody. Sorry that you've had to experience the inclement California weather, not what we anticipated, but definitely need the water. I just want to start off by saying that Tandem is a mission-driven company. We have 2,500 employees who are focused on improving the lives of people who live with diabetes through relentless innovation and extraordinary customer service. As a company, we have really focused on what we call user-centric design.

We work with the people who are using our products, and we analyze how they use it, and we work to basically make it as simple and as intuitive as possible. The -- I think that the benefits of that are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot